How Pharmas Can Help Private Health Insurers Achieve A Larger Role In China – McKinsey
This article was originally published in PharmAsia News
Executive Summary
Burgeoning private health insurance in China has room for growth, and pharmaceutical companies can lend a hand. Roche has led the way, and there is plenty for other multinational drug and device manufacturers to gain, according to a recent McKinsey report.